Tackling underlying respiratory conditions for this pandemic and next

During the COVID-19 pandemic, one of the many phrases that has become…


Infex appoints Lonza to manufacture new lung infection drug

Alderley Park, Cheshire Infex Therapeutics has awarded a £1m contract to Lonza…


Deals agreed as Infex’s resistance bypass drug program heads for clinic

Alderley Park, Cheshire Infex Therapeutics has appointed Pharmaron to help…


Infex focuses on pandemic preparedness with Covid patent

Infex Therapeutics has filed for a UK patent for a novel therapy designed to…


Infex Therapeutics and LifeArc in Collaboration to Defeat Superbugs

Infex Therapeutics has combined forces with medical research charity, LifeArc,…


Introducing Infex Therapeutics

The organisation leading UK efforts to tackle the health crisis around our…


The AMR Centre signs agreement to co-develop treatment for gonorrhoea

The AMR Centre (AMRC) has today announced a multi-year co-development…


AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

Alderley Park, UK The AMR Centre has nominated a preclinical candidate in…